Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02481154
Title Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Institut de Recherches Internationales Servier
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Oncology Center Los Angeles California 90024 United States Details
University of California San Francisco San Francisco California 94143 United States Details
University of Miami Miami Florida 33136 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
UT Southwestern Medical Center Dallas Texas 77030 United States Details
MD Anderson Cancer Center Houston Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field